https://techpapersworld.com/wp-content/uploads/2022/12/Neurocrine-Biosciences-Presents-Demographic-1280x720.jpg

Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, today reported demographic and clinical characteristics data from genetic screening-based studies of children with SCN8A-related epilepsies. Data was collected from more than 17,000 patients through Invitae Corporation’s Behind the Seizure® Program, of which Neurocrine Biosciences is a sponsor. The clinical characteristics of patients with pathogenic or likely pathogenic SCN8A variants were evaluated to assess the heterogeneity in the seizures and development of children with SCN8A-related epilepsies. These data (Poster #2.099: Demographic and Clinical...

https://techpapersworld.com/wp-content/uploads/2022/11/Serenus-AI-and-HealthTrio-Launch-an-AI-based-1280x720.jpg

Serenus.AI and HealthTrio are continuing an established partnership to launch an AI-based module to streamline and automate medical authorizations for knee replacements. As part of their joint “AI Prior-Auth Connect” project, their first module to streamline medical authorizations for knee replacements will be followed by modules for additional common elective surgeries. It is estimated that from the more than 700,000 knee replacement surgeries being conducted every year in the US, 30% are suspected as unjustified, risking patients’ lives,...

https://techpapersworld.com/wp-content/uploads/2022/11/Avail-Medsystems-to-Participate-in-the-Jefferies-1280x720.jpg

Avail, the digital hub of the operating room enabling the medical technology (MedTech) and healthcare industries to connect regardless of location and work smarter to advance patient care, today announced that Daniel Hawkins, Chief Executive Officer of Avail, will participate in a fireside chat at the Jefferies Virtual Private MedTech Summit on Tuesday, December 6, 2022 at 10:30 a.m. ET.

https://techpapersworld.com/wp-content/uploads/2022/11/AI-Predicts-Heart-Disease-1280x720.jpg

Researchers have developed a deep learning model that uses a single chest X-ray to predict the 10-year risk of death from a heart attack or stroke, stemming from atherosclerotic cardiovascular disease. Results of the study were presented today at the annual meeting of the Radiological Society of North America (RSNA). Deep learning is an advanced type of artificial intelligence (AI) that can be trained to search X-ray images to find patterns associated with disease. “Our deep learning model offers...

https://techpapersworld.com/wp-content/uploads/2022/11/IDTechEx-Discusses-Three-1280x720.jpg

The world of healthcare is undergoing significant change. The stress test of the pandemic, a growing global population, and increasing chronic disease prevalence is pushing care to be more efficient and robust. Technology is facilitating this transformation, and one significant form of wearable technology that is increasingly being adopted by healthcare systems is the electronic skin patch: wearables attached to the skin that can monitor physiology wirelessly and continuously. In their recent report “Electronic Skin...

https://techpapersworld.com/wp-content/uploads/2022/11/Natural-Killer-NK-Cell-Therapeutics-Market-1280x720.jpg

Data Bridge Market Research completed a qualitative study titled “Natural Killer (NK) Cell Therapeutics Market” with 100+ market data tables, pie charts, graphs, and figures spread across Pages and an easy to grasp full analysis. By keeping into focus customer requirements, an influential Natural Killer (NK) Cell Therapeutics market analysis report has been generated by chewing over quite a lot of market parameters. These factors consist of but are not limited to latest trends, market segmentation, new...

https://techpapersworld.com/wp-content/uploads/2022/11/BC-Platforms-Partners-with-EU-Funded-1280x720.jpg

BC Platforms (BCP), a global leader in healthcare data management and analytics, today announced that it has been chosen as key partner in a European Commission (EC) project. Under the EC’s Horizon Europe program*, Helsinki University Hospital (HUS), has been awarded a contract to lead a EURO 7 million (approx. USD 7.2 million) consortium project termed ONCOVALUE. BCP will work closely with HUS as a key delivery partner in this major EC project. ONCOVALUE is an Artificial Intelligence-based framework which...

https://techpapersworld.com/wp-content/uploads/2022/11/RCSI-Bahrain-announces-a-new-global-university-1280x720.jpg

The Royal College of Surgeons in Ireland – Medical University of Bahrain (RCSI Bahrain) has announced details of a new global university partnership involving its School of Nursing and Midwifery. This partnership is part of the University’s strategic aim to prepare its graduates to become global healthcare professionals. In October 2022, RCSI Bahrain hosted Professor Julie Green, Head of School of Nursing and Midwifery, Keele University, United Kingdom, for a new partnership launch under the Patronage of Her Excellency Dr Shaikha Rana Bint...

https://techpapersworld.com/wp-content/uploads/2022/11/3M-announces-strategic-1280x720.jpg

3M Health Information Systems (HIS) and Rad AI today announced a strategic sales partnership in which 3M will resell Rad AI’s Continuity incidental findings management and Omni impression generation solutions as a value-add to customers using 3MTM M*Modal Fluency for Imaging solution. “3M Fluency for Imaging and Rad AI’s Continuity and Omni are complementary solutions that help to support and strengthen the entire speech-driven reporting workflow,” said Michael Bee, 3M HIS vice president of clinician solutions. “Our goal in expanding this partnership is to provide...

https://techpapersworld.com/wp-content/uploads/2022/11/Lunit-Becomes-the-First-Medical-Software-1280x720.jpg

Lunit (KRX: 328130.KQ), a global provider of AI-powered cancer solutions, today announced that its AI solution suite for radiology, Lunit INSIGHT, has received the CE marking under Europe’s newest Medical Device Regulation (MDR). The Lunit INSIGHT product line also received the UK Conformity Assessed (UKCA) marking, obtaining commercial approval across both the UK and Europe. With these two markings, Lunit has become the first software as a medical device (SaMD) company in the Asia Pacific region to earn such accreditation....